Pneumocystis pneumonia following rituximab

Chest. 2014 Mar 1;145(3):663-664. doi: 10.1378/chest.13-2539.

Authors

Joshua D Farkas¹, Ryan D Clouser², Garth W Garrison²

Affiliations

¹ Department of Pulmonary and Critical Care, University of Vermont College of Medicine. Burlington, VT. Electronic address: farkasmd@gmail.com.
² Department of Pulmonary and Critical Care, University of Vermont College of Medicine. Burlington, VT.

PMID: 24590034
DOI: 10.1378/chest.13-2539

No abstract available

Publication types

Letter
Comment

MeSH terms

Antibodies, Monoclonal, Murine-Derived / adverse effects*
Antineoplastic Agents / adverse effects*
Female
Humans
Male
Opportunistic Infections / chemically induced*
Opportunistic Infections / epidemiology*
Pneumonia, Pneumocystis / chemically induced*
Pneumonia, Pneumocystis / epidemiology*

Substances

Antibodies, Monoclonal, Murine-Derived
Antineoplastic Agents